Apolipoprotein E genotype ε4/ε2 in the STANISLAS Cohort Study - Dominance of the ε2 allele?

Annals of Human Genetics

Volumn 60, Issue 6, 1996, Pages 509-516

  Bohnet, K ^a   Regis Bailly, A ^a   Vincent Viry, M ^a   Schlenck, A ^a   Gueguen, R ^a   Siest, G ^a   Visvikis, S ^a,b  

^a Centre du Medicament URA CNRS 597   (France)

^b Centre de Medecine Preventive   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CODOMINANCE; COHORT ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030454753     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-1809.1996.tb01617.x     Document Type: Article

References (27)

1. BOERWINKLE, E. & UTERMANN, G. (1988). Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am. J. Hum. Genet. 42, 104-112.
2. BOERWINKLE, E., VISVIKIS, S., WELSH, D., STEINMETZ, J., HANASH, S. M. & SING, C. F. (1987). The use of measured genotype information in the analysis of quantitative phenotypes in men. II. The role of apolipoprotein polymorphism in determining levels. variability and covariability of cholesterol, beta-lipoprotein and triglycerides in a sample of unrelated individuals. Am. J. Hum. Genet. 27, 567-582.
3. DALLONGEVILLE, J., LUSSIER-CACAN, S. & DAVIGNON, J. (1992) Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J. Lipid Res. 33. 447-454.
4. DAVIGNON, J., GREGG, R. E. & SING, C. F. (1988). Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8. 1-21.
5. DIXON, W. J., BROWN, M. B., ENGELMAN, L. & JENNRICH, R. I. (eds) (1990). BMDP Statistical Software Manual. Vol 1 and 2. University of California Press, Berkley.
6. EVANS, A. E., ZHANG, W , MOREEL, J. F. R., BARD, J. M., RICHARD, S., POIRIER, O., TIRET, L., FRUCHART, J. C. & CAMBIEN, F. (1993). Polymorphism of the apolipoprotein B and B genes and their relationship to plasma lipid variables in healthy Chinese men. Hum. Genet. 92, 191-197.
7. FRIEDEWALD, W. T., LEVY, R. I. & FREDRICKSON, D. S. (1972). Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin. Chem. 18. 499-502.
8. GARJA, B., CANDLISH, J. K., SAHA, N., MAK, J. W. & TAY, J. S. H. (1994). Effects of apolipoprotein E variants on plasma lipids and apolipoproteins in the Orang Asli ('Aborigines') of Malaysia. Hum. Hered. 44, 209-213.
9. HAVEKES, L. M., DE KNIJFF, P., SMITT, M. & FRANTS, R.R. (1988). The effect of apolipoprotein E allele substitutions on plasma lipid and apolipoprotein levels. Adv. Exp. Med Biol. 243. 87-93.
10. HIXSON, J. E. & VERNIER, D. T. (1990). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545-548.
11. KAMBOH, H. I., ASTON, C. E., FERRELL, R. E. & HAMMAN, R. F. (1993). Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis. 98. 201-211.
12. KESÄNIEMI, Y. A., EHNHOLM, C. & MIETTINEN, T. A. (1987). Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Invest. 80, 578-581.
13. KUUSI, T., NIEMINEN, S., EHNHOLM, C., YKI-JÄRVINEN, H., VALLE, M., NIKKILÄ, E. A. & TASKINEN, M.-R. (1989). Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis. 9, 237-241.
14. LUC, G., BARD, J.-M., ARVEILER, D., EVANS, A., CAMBOU, J.-P., BINGHAM, A., AMOUYEL, P., SCHAFFER, P., RUIDAVETS, J. B., CAMBIEN, F., FRUCHART, J. C. & DUCIMITIERE, P. (1994). Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler. Thromb. 14, 1412-1419.
15. LUCOTTE, G., VISVIKIS, S., LEININGER-MULLER, B., DAVID, F., BERRICHE, S., REVEILLEAU, S. & COUDERC, R. (1994). Association of apolipoprotein E allele 4 with late-onset sporadic Alzheimer's disease. Am. J. Med. Genet. 54, 286-288.
16. MIETTINEN, T. A., GYLLING, H., VANHANEN, H. & OLLUS, A. (1992). Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotype. Arterioscler. Thromb. 12, 1044-1052.
17. MILLER, S. A., DYKES, D. D. & POLESKY, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 6, 1215.
18. MOLL, P. P. (1993). Genetics of atherosclerosis: Some strategies for studies of apolipoprotein E. Am. J. Hum. Biol. 5, 451-460.
19. ORDOVAS, J M., LITWACK-KLEIN, L., WILSON, P. W., SCHAEFER, M. M. & SCHAEFER, E. J. (1987). Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J. Lipid Res. 28. 371-380.
20. PORKKA, K. V. K., TAIMELA, S., KONTULA, K., LEHTIMAKI, T., AALTO-SETALA, K., AKERBLOM, H. K. & VIIKARI, J. S. A. (1994). Variability gene effects of DNA polymorphisms at the apoB, apoAI/CIII and apoE loci on serum lipids: the Cardiovascular Risk in Young Finns Study. Clin. Genet. 45, 113-121.
21. SIEST, G., HENNY, J., GALTEAU, M. M., SCHIELE, F., STEINMETZ, J. & VISVIKIS, S. (1995). Lipid and lipoprotein genetic variability: An important contribution from the French health examination centers. Clin. Biochem. 28, 31-38.
22. SIEST, G., PILLOT, T., RÉGIS-BAILLY, A., LEININGER-MULLER, B., STEINMETZ, J., GALTEAU, M. M. & VISVIKIS, S. (1995). Apolipoprotein E: An important gene and protein to be followed in laboratory medicine. Clin. Chem. 41, 1068-1086.
23. SING, C. F. & DAVIGNON, J. (1985). Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37, 268-285.
24. SING, C. F. & MOLL, P. P. (1989). Genetics of variability of CHD risk. Int. J. Epidemiol 18, S183-S195.
25. STRITTMATTER, W. J., SAUNDERS, A. M., SCHMECHEL, D., PERICAK-VANCE, M., ENGHILD, J., SALVESEN, G. S. & ROSES, A. D. (1993). Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90, 1977-1981.
26. TIRET, L., DE KNIJFF, P., MENZEL, H. J., EHNHOLM, C., NICAUD, V. & HAVEKES, L. M. for the EARS group (1994). ApoE polymorphism and predisposition to coronary heart disease in youth of different European populations. Arterioscler. Thromb. 14, 1617-1624.
27. XHIGNESSE, M., LUSSIER-CACAN, S., SING, C. F., KESSLING, A. & DAVIGNON, J. (1991). Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler. Thromb. 11, 1100-1110.